Global Standard Quality for Japan and International Markets
Japan stands as a cornerstone in the global pharmaceutical industry, particularly in the manufacturing and export of high-purity hormone drugs. As the world's third-largest pharmaceutical market, Japan's rigorous standards set by the Pharmaceuticals and Medical Devices Agency (PMDA) ensure that hormone treatments produced here are of the highest efficacy and safety. The Japanese industry is currently undergoing a transformative phase, integrating Artificial Intelligence (AI) and biotechnology to refine hormone synthesis and delivery mechanisms.
For manufacturers and exporters in the region, the focus has shifted from traditional steroid production to advanced peptide hormones and localized endocrine therapies. This evolution is driven by Japan's aging population, necessitating sophisticated HRT (Hormone Replacement Therapy) solutions, and a booming high-tech agricultural sector that requires precise veterinary hormonal interventions.
Purity Standards
Export Regions
Certified Quality
R&D Process
Bridging Bio-Technology with Japan's Industrial Needs
In the cold waters of Hokkaido, the salmon industry relies heavily on hormonal precision. Manufacturers provide specialized spawning-promoting drugs that synchronize reproduction cycles, ensuring the sustainability of Japan's premium seafood exports. These treatments are essential for large-scale hatchery operations and the growing inland aquaculture facilities using recirculating aquaculture systems (RAS).
The reproduction of world-famous Wagyu cattle in regions like Kyushu and Hyogo demands the highest grade of Cloprostenol Sodium and Estradiol Benzoate. These hormones are used to manage estrus synchronization and treat reproductive disorders, ensuring that genetic lineages are preserved and productivity is maximized under the strict Japanese "Livestock Hygiene Service Center" guidelines.
In urban Japan, the veterinary market for companion animals (cats and dogs) is booming. Hormone drugs are increasingly used for complex endocrine conditions and reproductive health in high-end veterinary hospitals, where owners demand pharmaceutical-grade treatments that match human-level safety profiles.
Internationally, we have long-term trade relations with India, Southeast Asia, South Korea, and Japan. We provide products in the whole process of market and sales services. At the same time, we also provide product registration, consulting and sales channel expansion services for overseas companies in the Chinese market.
We are able to assemble and produce larger quantities of intermediates and provide some advanced, convenient manufacturing capabilities, including batch processing and customization. For the company's main product intermediates: We can maximize our advantages, meet the requirements of most customers and complete the task within the specified time limit.
The Future of Endocrinology and Hormone Export
Moving away from traditional chemical synthesis to microbial fermentation and recombinant DNA technology for cleaner, more sustainable hormone production.
Using hormones in conjunction with stem cell therapy to treat degenerative diseases, a field where Japan leads globally with iPSC research.
Implementing blockchain for the "Cold Chain" logistics of hormone drugs to ensure absolute stability and provenance from factory to clinic.
Utilizing machine learning to predict hormonal interactions and design side-effect-free synthetic analogs for specialized therapies.
Direct from Factory to the Japanese Market
SJ medical
